Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients.

Angeli G Rampersad Brian Boylan Connie H Miller Amy D Shapiro

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2018)

Assessment of anti-FVIII profiles along with the CBA may be useful to distinguish a clinically relevant low-titre FVIII inhibitor from a transient LA in HA patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
systemic lupus erythematosus
brain injury
disease activity